10x Genomics (TXG) EBITDA Margin (2018 - 2026)
10x Genomics (TXG) reported EBITDA Margin of -6.55% for Q2 2026, down 28.49 percentage points from 21.94% a year earlier and down 1.85 percentage points from the prior quarter.
10x Genomics (TXG) EBITDA Margin (2018 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, 10x Genomics' EBITDA Margin came in at -7.85%, up 2.55 percentage points year-over-year; for FY2025, it came in at -3.86%, up 22.12 percentage points from FY2024.
- EBITDA Margin has a five-year change of +170.19 percentage points (FY2020 to FY2025).
- By year, EBITDA Margin came in at -25.98% in FY2024 (+11.16 pp), -37.14% in FY2023 (-9.53 pp), -27.61% in FY2022 (-21.26 pp) and -6.35% in FY2021 (+167.70 pp).
- Five-year quarterly EBITDA Margin spans a low of -55.60% in Q3 2023 and a high of 21.94% in Q2 2025.
- Year over year, EBITDA Margin gained in six of the last eight quarters, with an average year-over-year change of +13.39 percentage points.
- The high point for year-over-year EBITDA Margin in five years was Q4 2021 (a gain of 354.50 percentage points); the low point was Q2 2022 (a drop of 44.70 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -4.70% (Q1 2026), -5.71% (Q4 2025) and -14.73% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 250.84 Bn | 229.99 Bn | 4.88 Bn | 24.20% |
| 2 | Abbott Laboratories | 174.73 Bn | 145.82 Bn | 7.27 Bn | 21.86% |
| 3 | Danaher | 159.85 Bn | 143.67 Bn | 3.61 Bn | 28.51% |
| 4 | Intuitive Surgical | 146.79 Bn | 126.35 Bn | 1.96 Bn | 41.08% |
| 5 | Medtronic | 114.54 Bn | 80.41 Bn | 6.34 Bn | 25.55% |
| 6 | Stryker | 105.67 Bn | 91.79 Bn | 4.50 Bn | 29.67% |
| 7 | Boston Scientific | 63.93 Bn | 58.94 Bn | 3.85 Bn | 28.17% |
| 8 | Becton Dickinson | 50.12 Bn | 47.27 Bn | 2.32 Bn | 24.62% |
| 9 | Edwards Lifesciences | 50.06 Bn | 34.17 Bn | 1.35 Bn | 31.93% |
| 10 | 10x Genomics | 11.53 Bn | 11.33 Bn | 112.50 Mn | -6.55% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -6.55% |
| Mar 31, 2026 | -4.70% |
| Dec 31, 2025 | -5.71% |
| Sep 30, 2025 | -14.73% |
| Jun 30, 2025 | 21.94% |
| Mar 31, 2025 | -20.21% |
| Dec 31, 2024 | -24.90% |
| Sep 30, 2024 | -21.44% |
| Jun 30, 2024 | -21.40% |
| Mar 31, 2024 | -37.09% |
| Dec 31, 2023 | -24.72% |
| Sep 30, 2023 | -55.60% |
| Jun 30, 2023 | -36.38% |
| Mar 31, 2023 | -33.89% |
| Dec 31, 2022 | -10.61% |
| Sep 30, 2022 | -25.82% |
| Jun 30, 2022 | -49.40% |
| Mar 31, 2022 | -31.04% |
| Dec 31, 2021 | -7.00% |
| Sep 30, 2021 | -8.13% |
10x Genomics EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=TXG&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "TXG", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=TXG&period=max&api_key=YOUR_API_KEY");
const data = await res.json();